Lexapro

Escitalopram, the active ingredient in Lexapro, is a selective serotonin reuptake inhibitor (SSRI) presented as an oral tablet for oral administration. It is used to treat major depressive disorder and generalized anxiety disorder, helping to improve mood and reduce anxiety symptoms in adult patients.

GNH USA supplies Lexapro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets. The company adheres to stringent quality standards and offers comprehensive logistics support for global distribution.

Lexapro (escitalopram) acts on the serotonergic system and is indicated for the following conditions: - Major depressive disorder: reduces depressive symptoms and improves overall mood. - Generalized anxiety disorder: alleviates excessive worry and anxiety. - Major depressive disorder (maintenance therapy): helps prevent relapse after remission.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient tension‑type headaches. - Insomnia: difficulty falling or staying asleep. - Dry mouth: reduced salivation. - Sexual dysfunction: decreased libido or delayed orgasm. - Dizziness: light‑headed sensation, especially on standing.

Serious or Rare Side Effects: - Serotonin syndrome: agitation, hyperthermia, muscle rigidity. - Suicidal thoughts: emergence of suicidal ideation, particularly in young adults. - Severe allergic reaction: rash, swelling, or anaphylaxis. - QT interval prolongation: cardiac rhythm disturbances. - Mania or hypomania: sudden mood elevation in susceptible individuals. - Hyponatremia: low blood sodium, especially in elderly patients.

Precautions should be observed when prescribing or dispensing Lexapro: - Assess for suicidal ideation: monitor patients closely during initiation and dose changes. - Avoid use in patients with known hypersensitivity to escitalopram or other SSRIs. - Caution in hepatic impairment: dose adjustment may be required. - Consider drug interactions: review concomitant serotonergic agents and other medications. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Lexapro may interact with other medicines; careful review is essential. Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Pimozide: increased risk of QT prolongation. - Thioridazine: potential for cardiac arrhythmias. Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened bleeding risk. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect. - Other serotonergic agents (e.g., tramadol, triptans): monitor for serotonin syndrome. - Carbamazepine: may reduce escitalopram plasma levels. - Alcohol: can increase CNS depression and impair judgment.